Next Article in Journal
Affinity Effects on the Release of Non-Conventional Antifibrotics from Polymer Depots
Next Article in Special Issue
Encapsulating TGF-β1 Inhibitory Peptides P17 and P144 as a Promising Strategy to Facilitate Their Dissolution and to Improve Their Functionalization
Previous Article in Journal
Reconciling Quality by Design and Transdermal Product Development
Previous Article in Special Issue
Perillaldehyde 1,2-epoxide Loaded SLN-Tailored mAb: Production, Physicochemical Characterization and In Vitro Cytotoxicity Profile in MCF-7 Cell Lines
Open AccessArticle

Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782-Santiago de Compostela, Spain
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2020, 12(3), 274; https://doi.org/10.3390/pharmaceutics12030274
Received: 20 January 2020 / Revised: 7 March 2020 / Accepted: 11 March 2020 / Published: 17 March 2020
(This article belongs to the Special Issue Nano-Micro Encapsulation of Drugs)
Electrospun nanofibers are gaining interest as ocular drug delivery platforms that may adapt to the eye surface and provide sustained release. The aim of this work was to design an innovative ophthalmic insert composed of hyaluronan (HA) nanofibers for the dual delivery of an antioxidant (ferulic acid, FA) and an antimicrobial peptide (ε-polylysine, ε-PL). Polyvinylpyrrolidone (PVP) was added to facilitate the electrospinning process. Fibers with diameters of approx. 100 nm were obtained with PVP 5%-HA 0.8% w/v and PVP 10%-HA 0.5% w/v mixtures in ethanol:water 4:6 v/v. An increase in PVP concentration to 20% w/v in both presence and absence of HA rendered fibers of approx. 1 µm. PVP 5%-HA 0.8% w/v fibers were loaded with 83.3 ± 14.0 µg FA per mg. After nanofibers crosslinking with ε-PL, blank and FA-loaded inserts showed a mean thickness of 270 ± 21 µm and 273 ± 41 µm, respectively. Blank and FA-loaded inserts completely released ε-PL within 30 min under sink conditions, whereas FA-loaded inserts released the antioxidant within 20 min. Both blank and FA-loaded inserts were challenged against Pseudomonas aeruginosa and Staphylococcus aureus, demonstrating their efficacy against relevant microbial species. View Full-Text
Keywords: ocular inserts; electrospinning; hyaluronan; ferulic acid; ε-polylysine; nanofibers ocular inserts; electrospinning; hyaluronan; ferulic acid; ε-polylysine; nanofibers
Show Figures

Figure 1

MDPI and ACS Style

Grimaudo, M.A.; Concheiro, A.; Alvarez-Lorenzo, C. Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery. Pharmaceutics 2020, 12, 274. https://doi.org/10.3390/pharmaceutics12030274

AMA Style

Grimaudo MA, Concheiro A, Alvarez-Lorenzo C. Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery. Pharmaceutics. 2020; 12(3):274. https://doi.org/10.3390/pharmaceutics12030274

Chicago/Turabian Style

Grimaudo, Maria A.; Concheiro, Angel; Alvarez-Lorenzo, Carmen. 2020. "Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery" Pharmaceutics 12, no. 3: 274. https://doi.org/10.3390/pharmaceutics12030274

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop